These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6375843)

  • 1. Calcium antagonists, cerebral ischemia and vasospasm.
    Weir B
    Can J Neurol Sci; 1984 May; 11(2):239-46. PubMed ID: 6375843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcium antagonists in cerebral arterial spasm.
    Allen GS
    Am J Cardiol; 1985 Jan; 55(3):149B-153B. PubMed ID: 3881907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium inhibitors: effects on cerebral blood flow and intracranial pressure].
    Payen D; Lamer C; Raggueneau JL
    Agressologie; 1989 Jun; 30(7):408-10. PubMed ID: 2817237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.
    Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H
    Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of nimodipine prophylaxis of cerebral vasospasm on anesthetic management during intracranial aneurysm clipping.
    Stullken EH; Johnston WE; Prough DS; Balestrieri FJ; McWhorter JM
    J Neurosurg; 1985 Feb; 62(2):200-5. PubMed ID: 3881564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage.
    Hongo K; Kobayashi S
    Neurol Res; 1993 Aug; 15(4):218-24. PubMed ID: 8105400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
    Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some considerations on cerebral vasospasm.
    Peterson EW; Leblanc R; Searle R; Mandy F
    Am Heart J; 1975 Jan; 89(1):124-6. PubMed ID: 234012
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemodynamic effects of nimodipine in patients anesthetized for cerebral aneurysm clipping.
    Stullken EH; Balestrieri FJ; Prough DS; McWhorter JM
    Anesthesiology; 1985 Mar; 62(3):346-8. PubMed ID: 3977118
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
    Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
    Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonist PY 108-068: demonstration of its efficacy in various types of experimental brain ischemia.
    Wiernsperger N; Gygax P; Hofmann A
    Stroke; 1984; 15(4):679-85. PubMed ID: 6464060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral arterial vasospasm in subarachnoid hemorrhage from ruptured intracranial aneurysm].
    Holyst J
    Pol Tyg Lek; 1977 Jul; 32(27):1063-6. PubMed ID: 331282
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Kassell NF; Sasaki T; Colohan AR; Nazar G
    Stroke; 1985; 16(4):562-72. PubMed ID: 3895589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin].
    Kido H; Uchida Y; Nakamura F; Sugimoto T
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):177-84. PubMed ID: 2196210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium blocking agents for treatment of cerebral vasospasm.
    Peck S
    J Neurosurg Nurs; 1983 Jun; 15(3):123-7. PubMed ID: 6553074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.